What is the pathogenesis of atherosclerosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Atherosclerosis is primarily caused by an inflammatory response to injury in the arterial wall, triggered by risk factors such as hypertension, hyperlipidemia, diabetes, and smoking 1.

Pathogenesis of Atherosclerosis

The process can be broken down into several key steps:

  • Initiation: Endothelial dysfunction and increased permeability, resulting from risk factors such as hypertension, hyperlipidemia, diabetes, and smoking, lead to endothelial injury and expression of adhesion molecules 1.
  • Monocyte Adhesion and Migration: Monocytes adhere to the endothelium and migrate into the intima, mediated by adhesion molecules (e.g., VCAM-1, ICAM-1) and chemokines (e.g., MCP-1) 1.
  • Macrophage Activation and Foam Cell Formation: Monocytes differentiate into macrophages, which ingest lipids and become foam cells, mediated by scavenger receptors (e.g., CD36, SR-A) and modified lipoproteins (e.g., oxidized LDL) 1.
  • Smooth Muscle Cell Proliferation and Migration: Smooth muscle cells migrate from the media to the intima and proliferate, mediated by growth factors (e.g., PDGF, TGF-β) and inflammatory cytokines (e.g., IL-1, TNF-α) 1.
  • Extracellular Matrix Accumulation: Smooth muscle cells produce extracellular matrix components (e.g., collagen, elastin), mediated by growth factors (e.g., TGF-β) and inflammatory cytokines (e.g., IL-1, TNF-α) 1.
  • Plaque Formation and Progression: Accumulation of lipids, macrophages, smooth muscle cells, and extracellular matrix leads to plaque formation and progression, complicated by inflammation, calcification, and thrombosis 1.
  • Clinical Manifestations: Atherosclerotic plaques can lead to various clinical manifestations, including myocardial infarction, stroke, peripheral artery disease, and aortic aneurysm 1. Some key points to note include:
  • Inflammation plays a crucial role in the pathogenesis of atherosclerosis, with circulating levels of inflammatory markers such as C-reactive protein (CRP) and interleukin-6 correlating with the clinical course and outcome of acute coronary syndromes 1.
  • Plaque disruption and thrombosis can be triggered by various factors, including physical or emotional stress, and can lead to acute coronary syndromes 1. Prevention and treatment strategies for atherosclerosis include:
  • Lifestyle modifications: diet, exercise, smoking cessation
  • Medications: statins (e.g., atorvastatin 20-80 mg/day), anti-hypertensives (e.g., ACE inhibitors, beta blockers), anti-platelet agents (e.g., aspirin 75-100 mg/day) 1.

From the Research

Pathogenesis of Atherosclerosis

The pathogenesis of atherosclerosis is a complex process involving multiple factors and cellular processes. Key factors that influence atherogenesis include:

  • Oxidative stress
  • Inflammation
  • Hypertension
  • Hyperlipidemia These factors ultimately drive the accumulation of low-density lipoprotein cholesterol within the arterial wall of medium and large arteries 2.

Cellular Processes

The accumulation of low-density lipoprotein cholesterol stimulates the infiltration of immune cells, such as:

  • Monocytes/macrophages
  • T-lymphocytes These cells take up the lipoprotein, leading to the formation of lipid-laden foam cells. Foam cell death results in increased accumulation of dead cells, cellular debris, and extracellular cholesterol, forming a lipid-rich necrotic core 2, 3.

Plaque Progression

Plaque progression is characterized by the formation of a fibrous cap composed of extracellular matrix proteins and smooth muscle cells. This cap acts to stabilize the atherosclerotic plaque. Degradation, thinning, and subsequent rupture of the fibrous cap leads to lumen-occlusive atherothrombosis, most commonly resulting in heart attack or stroke 2, 4.

Key Participants

Key initial participants in the pathogenesis of atherosclerosis include:

  • Focal intimal influx and accumulation of low-density lipoprotein (LDL)
  • Preferential recruitment of blood monocytes
  • Smooth muscle cell migration and proliferation
  • Formation of foam cells through the receptor-mediated uptake of oxidized LDL by macrophages 3, 5.

Inflammatory Insult

The inciting event of atherosclerosis is likely an inflammatory insult that occurs decades before the disease becomes clinically apparent. This insult initiates a series of changes in the constituent cellular make-up of the vessel wall, leading to the progression of atherosclerosis 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pathogenesis of atherosclerosis.

Seminars in nephrology, 1996

Research

The pathogenesis of atherosclerosis: atherogenesis and inflammation.

Laboratory investigation; a journal of technical methods and pathology, 1988

Research

Pathogenesis of atherosclerosis.

Hematology. American Society of Hematology. Education Program, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.